Funding priorities for regulatory systems strengthening in Africa

Funding priorities for regulatory systems strengthening in Africa Funding priorities for regulatory systems strengthening in Africa Introduction This Briefing Note highlights ten key priorities that investors should consider if they want to support the African continent’s aim to provide equitable access to safe and effective vaccines and significantly increase local production of these in the next. [...] For effective regulatory system strengthening in Africa, investments should collectively address the needs at the national, regional and continental level, building on existing initiatives and priorities as guided by the African Medicines Regulatory Harmonisation initiative (AMRH) and the Partnership for African Vaccine Manufacturing (PAVM). [...] These opportunities are aligned with the ambitions of the Partnerships for African Vaccines Manufacturing (PAVM) Framework for Action (2022), the workplan of the African Medicines Harmonisation Initiative (AMRH), the goals of the African Medicines Agency (AMA) and the African Union’s ambition to substantially increase the availability of African-produced vaccines on the continent by 20401. [...] The foci of the AMA will framework for the regulatory workforce be limited initially, and the current treaty does not and regional baseline assessments of provide for any binding decisions. [...] Support regional assessments of human examine issues which might challenge the resource needs and development of an effectiveness of the Agency and its constituent educational and training strategy for the parts in the oversight of vaccines and medicines.